These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Obesity, diabetes, and insulin resistance: implications from molecular biology, epidemiology, and experimental studies in humans and animals. Synopsis of the American Diabetes Association's 29th Research Symposium and Satellite Conference of the 7th International Congress on Obesity, Boston, Massachusetts. Hansen BC Diabetes Care; 1995 Jun; 18(6):A2-9. PubMed ID: 7555497 [TBL] [Abstract][Full Text] [Related]
3. National Diabetes Month. Spotlight on type 2 diabetes in kids. Dairman T Diabetes Self Manag; 2003; 20(6):25, 27. PubMed ID: 14971335 [No Abstract] [Full Text] [Related]
4. The role of obesity in diabetes. Turner RC Int J Obes Relat Metab Disord; 1992 Dec; 16 Suppl 2():S43-6. PubMed ID: 1335989 [No Abstract] [Full Text] [Related]
5. [The interconnections of molecular mechanisms of hormone actions and their role in pathogenesis of obesity, insulin resistance, and diabetes mellitus]. Pankov IuA; Chekhranova MK; Karpova SK Vestn Ross Akad Med Nauk; 2008; (3):28-36. PubMed ID: 18421906 [TBL] [Abstract][Full Text] [Related]
6. Resistin: an adipocyte-derived hormone. Has it a role in diabetes and obesity? Rea R; Donnelly R Diabetes Obes Metab; 2004 May; 6(3):163-70. PubMed ID: 15056123 [No Abstract] [Full Text] [Related]
7. [Physiopathology of insulin resistance, obesity and type II diabetes in animals]. Jeanrenaud B; Assimacopoulos-Jeannet F; Greco-Perotto R; Halimi S; Ionescu E; Pénicaud L; Rohner-Jeanrenaud F; Terretaz J; Van de Werve G; Zaninetti D Journ Annu Diabetol Hotel Dieu; 1988; ():7-14. PubMed ID: 3050236 [No Abstract] [Full Text] [Related]
8. Resistin--resistant to defining its role. Smith U Obes Res; 2002 Jan; 10(1):61-2. PubMed ID: 11786603 [No Abstract] [Full Text] [Related]
9. Risk of obesity in type II diabetes mellitus. Berger M Int J Obes Relat Metab Disord; 1992 Dec; 16 Suppl 4():S29-33. PubMed ID: 1338384 [TBL] [Abstract][Full Text] [Related]
14. PAR-5359, a well-balanced PPARalpha/gamma dual agonist, exhibits equivalent antidiabetic and hypolipidemic activities in vitro and in vivo. Kim MK; Chae YN; Son MH; Kim SH; Kim JK; Moon HS; Park CS; Bae MH; Kim E; Han T; Choi HH; Shin YA; Ahn BN; Lee CH; Lim JI; Shin CY Eur J Pharmacol; 2008 Oct; 595(1-3):119-25. PubMed ID: 18727927 [TBL] [Abstract][Full Text] [Related]
15. Telmisartan is a promising cardiometabolic sartan due to its unique PPAR-gamma-inducing property. Yamagishi S; Takeuchi M Med Hypotheses; 2005; 64(3):476-8. PubMed ID: 15617852 [TBL] [Abstract][Full Text] [Related]
16. [Type 2 diabetes among adolescents in Israel]. Pinhas-Hamiel O; Koren I; Vardi P Harefuah; 2000 Feb; 138(3):186-9, 271. PubMed ID: 10883089 [TBL] [Abstract][Full Text] [Related]
17. MiR-130b promotes obesity associated adipose tissue inflammation and insulin resistance in diabetes mice through alleviating M2 macrophage polarization via repression of PPAR-γ. Zhang M; Zhou Z; Wang J; Li S Immunol Lett; 2016 Dec; 180():1-8. PubMed ID: 27746169 [TBL] [Abstract][Full Text] [Related]
18. Tumor necrosis factor alpha: a key component of the obesity-diabetes link. Hotamisligil GS; Spiegelman BM Diabetes; 1994 Nov; 43(11):1271-8. PubMed ID: 7926300 [TBL] [Abstract][Full Text] [Related]
20. Lack of association between the Pro12Ala polymorphism in PPAR-gamma2 gene and body weight changes, insulin resistance and chronic diabetic complications in obese patients with type 2 diabetes. Stefanski A; Majkowska L; Ciechanowicz A; Frankow M; Safranow K; Parczewski M; Pilarska K Arch Med Res; 2006 Aug; 37(6):736-43. PubMed ID: 16824933 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]